← Open Payments lookup

KAREN GOING: Open Payments

NPI 1588962369 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,449 in 65 payments from 15 companies in 2025. Trend: 2023 $211 · 2024 $836 · 2025 $1,449

Food & beverage: $1,449
CompanyPaymentsAmount
GlaxoSmithKline, LLC.13$251
Novo Nordisk Inc10$207
Lilly USA, LLC6$204
E.R. Squibb & Sons, L.L.C.5$177
Lundbeck LLC5$145
Bayer Healthcare Pharmaceuticals Inc.7$133
Phathom Pharmaceuticals, Inc.6$57
Exact Sciences Corporation2$54
AstraZeneca Pharmaceuticals LP3$53
Boehringer Ingelheim Pharmaceuticals, Inc.2$39

Products named: COBENFY, REXULTI, SHINGRIX, Kerendia, MOUNJARO, TRELEGY ELLIPTA, Ozempic, ZEPBOUND.

Industry payments across DC — which companies pay providers there.